Table 1.
Gene | Immune pathway | Contributes to anti (-) or pro (+) inflammatory phenotype a |
---|---|---|
TNFα (TNF)b | Common end product of many innate and adaptive immune pathways | + |
IFNγ (IFNG)b | Th1 effector cytokine | + |
IL-12 (IL12A)b | Promotes differentiation to Th1 effector cells | + |
T-bet (TBX21)b | Transcription factor utilised by Th1 cells | + |
IL-23 (IL23A)b | Promotes differentiation to Th17 phenotype | + |
IL-27 (IL27)b | Inhibits differentiation to Th17 phenotype | - |
RORγT (RORC)b | Transcription factor utilised by Th17 cells | + |
IL-10 (IL10)b | Anti-inflammatory cytokine produced by many T cell subtypes and some macrophages | - |
Foxp3 (FOXP3)b | Transcription factor utilised by naturally occurring CD4+ CD25+ Treg cells | - |
GATA3 (GATA3)b | Transcription factor utilised by Th2 cells | - |
aCytokines and transcription factors will have diverse actions under different conditions and the descriptions above are primarily for illustrative purposes and are not exhaustive; bdenotes official gene name as described by the HUGO Gene Nomenclature Committee (HGNC). Foxp3, forkhead box P3; GATA3, GATA-binding protein 3; IFNγ, interferon gamma; IL-12, interleukin 12; IL-23, interleukin 23; IL-27, interleukin 27; RORγt, RAR-related orphan receptor gamma T; Th1, T-helper cell type 1; Th17, T-helper cell type 17; Th2, T-helper cell type 2; TNFɑ, tumour necrosis factor alpha; Treg, T regulatory cell.